Form 8-K - Current report:
SEC Accession No. 0001558370-23-010811
Filing Date
2023-06-05
Accepted
2023-06-05 16:15:12
Documents
12
Period of Report
2023-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K edit-20230601x8k.htm   iXBRL 8-K 49061
  Complete submission text file 0001558370-23-010811.txt   166140

Data Files

Seq Description Document Type Size
2 EX-101.SCH edit-20230601.xsd EX-101.SCH 3148
3 EX-101.LAB edit-20230601_lab.xml EX-101.LAB 15238
4 EX-101.PRE edit-20230601_pre.xml EX-101.PRE 9829
6 EXTRACTED XBRL INSTANCE DOCUMENT edit-20230601x8k_htm.xml XML 4626
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 23992640
SIC: 2836 Biological Products, (No Diagnostic Substances)